SACK1A and breast carcinoma: Concordantly, silencing FAM83A markedly decreased the proliferation, anchorage-independent growth and invasion capabilities of breast cancer cells both in vitro and in vivo,19 further supporting the suggestion that FAM83A represents a potential target for cancer therapy.